الفهرس | Only 14 pages are availabe for public view |
Abstract This study aimed at evaluation of the presence of ACA IgG and IgM in chronic hepatitis C infected patients. The study was carried out on 59 chronic hepatitis C infected patients and 21 healthy control. All the patients were HCV-RNA positive confirmed by PCR, HBs Ag and HIV negative. Non of our patients was receiving interferon theraphy during the study. All patients and controls were subjected to the following : 1-Full clinical evaluation : including history taking and full clinical examination . 2-Fasting blood sample was drown from each person and subjected to: a-platelet count. b-AST ,ALT & y GT . c-ACA IgM & IgG. The statistical analysis of the study showed : 1-There was a significant decrease in platelet count in chronic HCV infected patients compared with control group. 2-There was a significant increase in AST serum levels in chronic HCV infected patients compared with control group. 3-There was a significant increase in ALT serum levels in chronic HCV infected patients compared with control group. 4 -There was a significant increase in yGT serum levels in chronic HCV patients compared with control group. 5-15 of our patients were ACA/IgG positive while 44 patients were ACA IgG negative. The percentage of positivity was 25.42%. Non of the controls was ACA IgG positive. The percentage of positivity was 0%. There was a significant increase in ACA IgG serum levels in chronic HCV patients compared with control group. 6-Only lof our patients was ACA IgM positive while 58 patients was ACA IgM negative.The percentage of positivity was 1.69%. Non of the controls was ACA IgM positive. Thepercentage of positivity was 0%.There was non significant increase in ACA IgM in chronic HCV compared with control group. 7-There was non significant difference between ACA IgG positive and negative cases as regard age and ALT serum levels. 8-There was a significant increase in ACA IgG positive cases compared with ACA Igo negative cases as regard female to male ratio . 9-There was a significant decrease in platelet count in ACA IgG positive cases compared with ACA IgG negative cases. 10-The presence of thrombotic events and portal hypertension was related to the positivity of ACA IgG. from this results we concluded that: 1- HCV infection is associated with a high prevalence of ACA. 2- ACA might be responsible for the high incidence of thrombocytopenia and thrombotic events in HCV patients. 3- HCV might be an additional recognized cause of APS. |